International Clinical Trial: Development of a Novel Non-Invasive Diagnostic Tool for Autoimmune Epilepsy Based on Oral and Gut Microbiome Metagenomic and Metabolomic Data

Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124181) titled 'Development of a Novel Non-Invasive Diagnostic Tool for Autoimmune Epilepsy Based on Oral and Gut Microbiome Metagenomic and Metabolomic Data' on May 8.

Study Type: Observational study

Study Design: Factorial

Primary Sponsor: The First Affiliated Hospital of Zhengzhou University

Condition: Autoimmune epilepsy

Intervention: acute symptomatic seizures secondary to autoimmune encephalitis(ASSAE) group:No

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2025-11-06

Target Sample Size: acute symptomatic seizures secondary to autoimmune encephalitis(ASSAE) group:30;autoimmune-associated e...